Form 8-K - Current report:
SEC Accession No. 0001504776-23-000003
Filing Date
2023-02-28
Accepted
2023-02-28 06:58:29
Documents
13
Period of Report
2023-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K wrby-20230228.htm   iXBRL 8-K 36897
2 EX-99.1 warbyparkerincearningsrele.htm EX-99.1 388176
  Complete submission text file 0001504776-23-000003.txt   597283

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT wrby-20230228.xsd EX-101.SCH 1899
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT wrby-20230228_lab.xml EX-101.LAB 25848
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT wrby-20230228_pre.xml EX-101.PRE 13579
7 EXTRACTED XBRL INSTANCE DOCUMENT wrby-20230228_htm.xml XML 12095
Mailing Address 233 SPRING STREET 6TH FLOOR EAST NEW YORK NY 10013
Business Address 233 SPRING STREET 6TH FLOOR EAST NEW YORK NY 10013 (646) 847-7215
Warby Parker Inc. (Filer) CIK: 0001504776 (see all company filings)

EIN.: 800423634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40825 | Film No.: 23678297
SIC: 3851 Ophthalmic Goods